150 related articles for article (PubMed ID: 24796622)
21. Carboxyl terminal glycine extended progastrin (gastrin-G) in gastric antral mucosa of patients with gastric or duodenal ulcer and in gastrinomas.
Azuma T; Magami Y; Habu Y; Kawai K; Taggart RT; Walsh JH
J Gastroenterol Hepatol; 1990; 5(5):525-9. PubMed ID: 2129824
[TBL] [Abstract][Full Text] [Related]
22. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.
Goetze JP; Eiland S; Svendsen LB; Vainer B; Hannibal J; Rehfeld JF
Scand J Gastroenterol; 2013 Jun; 48(6):688-95. PubMed ID: 23544442
[TBL] [Abstract][Full Text] [Related]
23. Progastrin and cyclooxygenase-2 in colorectal cancer.
Konturek PC; Bielanski W; Konturek SJ; Hartwich A; Pierzchalski P; Gonciarz M; Marlicz K; Starzynska T; Zuchowicz M; Darasz Z; Götze JP; Rehfeld JF; Hahn EG
Dig Dis Sci; 2002 Sep; 47(9):1984-91. PubMed ID: 12353842
[TBL] [Abstract][Full Text] [Related]
24. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis.
Konturek SJ; Gonciarz M; Gonciarz Z; Bielanski W; Mazur W; Mularczyk A; Konturek PC; Goetze JP; Rehfeld JF
Scand J Gastroenterol; 2003 Jun; 38(6):643-7. PubMed ID: 12825873
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Waldum HL; Syversen U
Cancer; 1999 Oct; 86(7):1377-8. PubMed ID: 10506728
[No Abstract] [Full Text] [Related]
26. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL
Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408
[TBL] [Abstract][Full Text] [Related]
27. In vivo immunosorption--a method for the examination of hormone heterogeneity at low plasma concentrations. Application to progastrin and its products.
Rehfeld JF
J Immunol Methods; 1992 Aug; 153(1-2):7-19. PubMed ID: 1517603
[TBL] [Abstract][Full Text] [Related]
28. Identification of progastrin derived peptides in colorectal carcinoma extracts.
Nemeth J; Taylor B; Pauwels S; Varro A; Dockray GJ
Gut; 1993 Jan; 34(1):90-5. PubMed ID: 8432459
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis.
Nicolaou A; Thomas D; Alexandraki KI; Sougioultzis S; Tsolakis AV; Kaltsas G
Neuroendocrinology; 2014; 99(2):118-22. PubMed ID: 24776735
[TBL] [Abstract][Full Text] [Related]
30. Source of plasma chromogranin A elevation in gastrinoma patients.
Stabile BE; Howard TJ; Passaro E; O'Connor DT
Arch Surg; 1990 Apr; 125(4):451-3. PubMed ID: 2322109
[TBL] [Abstract][Full Text] [Related]
31. Increased gastrin precursor secretion in preterm infants and their mothers at birth.
Törnhage CJ; Rehfeld JF
J Pediatr Endocrinol Metab; 2000; 13(9):1563-70. PubMed ID: 11154151
[TBL] [Abstract][Full Text] [Related]
32. Brief report: a duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations.
Zimmer T; Stölzel U; Bäder M; Fett U; Foss HD; Riecken EO; Rehfeld JF; Wiedenmann B
N Engl J Med; 1995 Sep; 333(10):634-6. PubMed ID: 7637724
[No Abstract] [Full Text] [Related]
33. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
34. Identification of gastrin molecular variants in gastrinoma syndrome.
Kothary PC; Mahoney WC; Vinik AI
Regul Pept; 1987 Feb; 17(2):71-84. PubMed ID: 3554401
[TBL] [Abstract][Full Text] [Related]
35. Identification of progastrin in gastrinomas, antrum, and duodenum by a novel radioimmunoassay.
Pauwels S; Desmond H; Dimaline R; Dockray GJ
J Clin Invest; 1986 Feb; 77(2):376-81. PubMed ID: 3753710
[TBL] [Abstract][Full Text] [Related]
36. Processing and proliferative effects of human progastrin in transgenic mice.
Wang TC; Koh TJ; Varro A; Cahill RJ; Dangler CA; Fox JG; Dockray GJ
J Clin Invest; 1996 Oct; 98(8):1918-29. PubMed ID: 8878444
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin A assay in clinical practice.
d'Herbomez M; Do Cao C; Vezzosi D; Borzon-Chasot F; Baudin E;
Ann Endocrinol (Paris); 2010 Sep; 71(4):274-80. PubMed ID: 20538257
[TBL] [Abstract][Full Text] [Related]
38. Expression of progastrin-derived peptides and gastrin receptors in a panel of gastrointestinal carcinoma cell lines.
Kelly A; Hollande F; Shulkes A; Baldwin GS
J Gastroenterol Hepatol; 1998 Feb; 13(2):208-14. PubMed ID: 10221825
[TBL] [Abstract][Full Text] [Related]
39. Criteria for the glucagon provocative test in the diagnosis of gastrinoma.
Shibata C; Kakyo M; Kinouchi M; Tanaka N; Miura K; Naitoh T; Ogawa H; Motoi F; Egawa S; Ueno T; Naito H; Unno M
Surg Today; 2013 Nov; 43(11):1281-5. PubMed ID: 22983734
[TBL] [Abstract][Full Text] [Related]
40. Disturbed progastrin processing in carboxypeptidase E-deficient fat mice.
Lacourse KA; Friis-Hansen L; Rehfeld JF; Samuelson LC
FEBS Lett; 1997 Oct; 416(1):45-50. PubMed ID: 9369230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
